| Full Name | Harbour House, Inc |
|---|---|
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 5 Oak Ct, Annapolis, Maryland |
| Authorized Official Name and Position | Roger Riley (CLINICAL DIRECTOR) |
| Authorized Official Contact | 4102553539 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Harbour House, Inc Po Box 3603 Baltimore MD 21214-0603 Ph: (410) 255-3539 | Harbour House, Inc 5 Oak Ct Annapolis MD 21401-7017 Ph: (410) 266-3040 |
| NPI Number | 1336654474 |
|---|---|
| Provider Enumeration Date | 12/12/2017 |
| Last Update Date | 12/15/2017 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336654474 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 905693 (Maryland) | Primary |
News Archive
Changing the microbial environment in the gut in autistic children could substantially reduce the severity of the symptoms they experience, according to new research.
Takeda Pharmaceutical Company Limited ("Takeda") today announced that a Marketing Authorisation Application (MAA) has been submitted to The European Medicines Agency (EMA) for vedolizumab, an investigational, gut-selective humanized monoclonal antibody for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD), the two most common types of inflammatory bowel disease (IBD).
Drug addiction investigators with joint appointments at Columbia University Medical Center and the New York State Psychiatric Institute along with MediciNova Inc, a biopharmaceutical company publicly traded on the Nasdaq Global Market and the Jasdaq Market of the Osaka Securities Exchange, today reported preliminary results of the company's neurological drug candidate, ibudilast (MN-166/AV411), in a Phase 1b/2a trial in opioid addicts. The study was largely funded by the National Institute on Drug Abuse (NIDA) with MediciNova supplementation.
GENova Biotherapeutics, Inc., ("GENova"), a biotechnology company that develops novel therapeutic proteins that disrupt the advance of life-threatening diseases, is pleased to announce that it is in the process of acquiring three promising new drug target patents that could generate over a billion dollar in royalty fees in the mid to long term.
Mary Fanning, South Africa's country coordinator for PEPFAR, writes in a New Age guest column, "In the fight against HIV/AIDS, this is a time of hope. It's also a time to celebrate the partnerships that are advancing this work and to recommit to a plan to ensure prevention, treatment and care for those infected and affected is sustainable and locally managed."
› Verified 5 days ago
Tricia Burke, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1187 Saint George Dr, Annapolis, MD 21409 Phone: 808-341-4742 | |
Lumate Florida Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3151 Catrina Ln, Annapolis, MD 21403 Phone: 917-304-0679 | |
Guiding Minds Therapeutic Counseling Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2525 Riva Rd, Annapolis, MD 21401 Phone: 240-277-3422 | |
Grow On Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1702 Marissa Way, Annapolis, MD 21401 Phone: 443-203-8469 | |
Lee F. Owens, Ed.d. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 116 Defense Hwy, Suite 210, Annapolis, MD 21401 Phone: 410-224-2021 Fax: 410-224-2420 | |
Project Chesapeake Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 108 Old Solomons Island Rd, Building 2 Suite 1, Annapolis, MD 21401 Phone: 443-214-5097 Fax: 443-378-8538 | |
Rogue River Counseling, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2007 Tidewater Colony Dr Ste 1a, Annapolis, MD 21401 Phone: 410-294-9300 Fax: 410-294-9300 |